The proposed FIRCA project will be carried out primarily in the Institute of Analytical Chemistry in Prague, Czech Republic, in collaboration with Dr. Jiri Dedina as an extension of NIH Grant 1 R01 ES010845. The metabolism of inorganic arsenic (iAs) in humans involves reduction and methylation reactions that produce methylated trivalent and pentavalent arsenicals. The liver is likely the major site for methylation of iAs in human body. The methylated trivalent arsenicals, unlike their pentavalent counterparts, are more potent than iAs as cytotoxins, genotoxins, enzyme inhibitors, and as modulators of major signal transduction pathways in human cells. Thus, formation of these species in the methylation pathway for iAs is often regarded as a mechanism for activation of this metalloid as a toxin and carcinogen. The interindividual variations in the capacity of the liver to methylate iAs may underlie differences in the susceptibility of individuals to toxic and carcinogenic effects associated with acute and chronic exposures to iAs. The proposed FIRCA project is an extension of the parent NIH-funded project that examines qualitative and quantitative aspects of the interindividual variations in the metabolism of iAs in human hepatic tissue and in primary human hepatocytes obtained from a significant number of donors. In the parent project, trivalent and pentavalent metabolites of iAs are analyzed in tissues and in hepatocyte cultures exposed to various concentrations of iAs, using the oxidation state specific hydride-generation (HG)-atomic absorption spectrometry (AAS). This method is uniquely suited for the speciation analysis of arsenic in complex biological matrices. However, it lacks sensitivity that is required for analysis of small amounts of metabolites generated under conditions of low iAs exposures. The goal of the proposed FIRCA project is to optimize the HG methodology and instrumentation to increase sensitivity of the arsenic speciation analyses by AAS or by atomic fluorescence spectrometry. The optimized HG systems will then be used in the parent project for analysis of metabolites produced by human hepatocytes exposed to low concentrations of iAs that are consistent with chronic environmental exposures. Importantly, the ultimate goal of the proposed research is to further improve the capacity of widely-used HG-based analytical techniques to analyze iAs metabolites, particularly the toxic methylated trivalent intermediates, in body fluids and tissues of individuals exposed to low concentrations of iAs from the environment.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW007057-02
Application #
6935931
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Program Officer
Schonwalder, Chris
Project Start
2004-08-01
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2006-07-31
Support Year
2
Fiscal Year
2005
Total Cost
$40,320
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pediatrics
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hernandez-Zavala, Araceli; Drobna, Zuzana; Styblo, Miroslav et al. (2009) Analysis of arsenical metabolites in biological samples. Curr Protoc Toxicol 42:4.33.1-4.33.17
Drobna, Zuzana; Styblo, Miroslav; Thomas, David J (2009) An Overview of Arsenic Metabolism and Toxicity. Curr Protoc Toxicol 42:4.31.1-4.31.6
Drobna, Zuzana; Styblo, Miroslav; Thomas, David J (2009) In vitro assays of inorganic arsenic methylation. Curr Protoc Toxicol 42:4.32.1-4.32.10
Hernandez-Zavala, Araceli; Valenzuela, Olga L; Matousek, Tomas et al. (2008) Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water. Environ Health Perspect 116:1656-60
Matousek, Tomas; Hernandez-Zavala, Araceli; Svoboda, Milan et al. (2008) Oxidation State Specific Generation of Arsines from Methylated Arsenicals Based on L- Cysteine Treatment in Buffered Media for Speciation Analysis by Hydride Generation - Automated Cryotrapping - Gas Chromatography-Atomic Absorption Spectrometry with the Spectrochim Acta Part B At Spectrosc 63:396-406
Hernandez-Zavala, Araceli; Matousek, Tomas; Drobna, Zuzana et al. (2008) Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J Anal At Spectrom 23:342-351
Musil, Stanislav; Matousek, Tomas (2008) On-line pre-reduction of pentavalent arsenicals by thioglycolic acid for speciation analysis by selective hydride generation-cryotrapping-atomic absorption spectrometry. Spectrochim Acta Part B At Spectrosc 63:685-691
Hughes, Michael F; Devesa, Vicenta; Adair, Blakely M et al. (2008) Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. Toxicol Appl Pharmacol 227:26-35
Paul, David S; Hernandez-Zavala, Araceli; Walton, Felecia S et al. (2007) Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol 222:305-14
Devesa, Vicenta; Adair, Blakely M; Liu, Jie et al. (2006) Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 224:147-55

Showing the most recent 10 out of 11 publications